论文信息 - Tumor-agnostic ctDNA levels by mFAST-SeqS in first-line HR-positive, HER2 negative metastatic breast cancer patients as a biomarker for survival - 字舞流文

Tumor-agnostic ctDNA levels by mFAST-SeqS in first-line HR-positive, HER2 negative metastatic breast cancer patients as a biomarker for survival

S. Sleijfer | M. Smid | A. Jager | S. Wilting | J. Kraan | V. de Weerd | J. Drooger | J. Heijns | Noortje Verschoor | Annemieke van der Padt-Pruijsten | J. M. Zuetenhorst | M. Van | J. Martens | Vanja de Weerd | S. Wilting